======= GLYATL2 =======
== Gene Information ==
* **Official Symbol**: GLYATL2
* **Official Name**: glycine-N-acyltransferase like 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=219970|219970]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8WU03|Q8WU03]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=GLYATL2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GLYATL2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614762|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Mitochondrial acyltransferase which transfers the acyl group to the N-terminus of glycine. Conjugates numerous substrates, such as arachidonoyl-CoA and saturated medium and long-chain acyl-CoAs ranging from chain-length C8:0-CoA to C18:0- CoA, to form a variety of N-acylglycines. Shows a preference for monounsaturated fatty acid oleoyl-CoA (C18:1-CoA) as an acyl donor. Does not exhibit any activity toward C22:6-CoA and chenodeoxycholoyl-CoA, nor toward serine or alanine. {ECO:0000269|PubMed:20305126}.
|Gly acyl tr N|
|Gly acyl tr C|
|monounsaturated fatty acid catabolic process|
|monounsaturated fatty acid metabolic process|
|medium-chain fatty acid catabolic process|
|glycine N-acyltransferase activity|
|long-chain fatty acid catabolic process|
|medium-chain fatty acid metabolic process|
|fatty acid catabolic process|
|unsaturated fatty acid metabolic process|
|long-chain fatty acid metabolic process|
|monocarboxylic acid catabolic process|
|cellular lipid catabolic process|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|lipid catabolic process|
|fatty acid metabolic process|
|small molecule catabolic process|
|monocarboxylic acid metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxoacid metabolic process|
|endoplasmic reticulum|
|organic acid metabolic process|
|lipid metabolic process|
|mitochondrion|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp359|FK-506 30μM R07 exp359]]|1.73|
|[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.75|
|[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|1.77|
|[[:results:exp149|SB203580 25μM R03 exp149]]|1.84|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8935
* **Expression level (log2 read counts)**: -3.13
{{:chemogenomics:nalm6 dist.png?nolink |}}